The World of Health & Medicine News

Chew On This: Scientists Create Gum That Traps Herpes, Flu Viruses

Chew On This: Scientists Create Gum That Traps Herpes, Flu Viruses

The battle against common viral infections might soon include an unexpected weapon: chewing gum. Researchers at the University of Pennsylvania have created a specialized gum that could trap and neutralize herpes and influenza viruses before they spread or cause infection.

A plant-based chewing gum made from lablab beans can trap and neutralize flu and herpes viruses in the lab, offering a potential new way to reduce transmission directly in the mouth, where these viruses often spread.

The antiviral protein in the gum (FRIL) stays stable for over two years at room temperature, making it a promising option for global use without the need for refrigeration or injections.

Though results so far are limited to lab tests, the gum has passed safety checks and is now approved for clinical trials, which will help determine whether it actually prevents infection in people./ Molecular Therapy

spot_img

Explore more

spot_img

Novartis and Sanofi CEOs say EU should raise drug prices in...

Novartis and Sanofi CEOs say EU should raise drug prices in face of tariffs The European Union should allow drug prices to rise to U.S....

Roche to invest $50 billion in US to avoid Trump tariffs,...

Roche to invest $50 billion in US to avoid Trump tariffs, create 12,000 jobs Roche said on Tuesday it would invest $50 billion in the...

5 Fruits with More Fiber Than a Bowl of Oatmeal, According...

5 Fruits with More Fiber Than a Bowl of Oatmeal, According to a Dietitian Almost all of us could use more fiber. Even though we’re supposed...

8 Signs You Should See a Gastroenterologist, According to Gut Doctors

8 Signs You Should See a Gastroenterologist, According to Gut Doctors You may overlook these signs, but being proactive can help prevent more serious issues...

Gilead says Trodelvy-Keytruda combo effective for aggressive breast cancer type

Gilead says Trodelvy-Keytruda combo effective for aggressive breast cancer type  Gilead Sciences (GILD.O), opens new tab said on Monday a late-stage study showed that its drug Trodelvy...

Abu Dhabi’s M42 partners with UK firm to develop AI-driven therapeutics...

Abu Dhabi's M42 partners with UK firm to develop AI-driven therapeutics for age-related diseases Abu Dhabi's M42 has announced a partnership and investment in UK-based...

UK approves combination therapies of GSK’s blood cancer drug Blenrep

UK approves combination therapies of GSK's blood cancer drug Blenrep GSK (GSK.L), opens new tab said on Thursday two combination therapies with its cancer drug, Blenrep, have...

US FDA limits industry employees from roles in its advisory committees

US FDA limits industry employees from roles in its advisory committees U.S. Food and Drug Administration Commissioner Martin Makary announced on Thursday a policy to...